ALLEN JOHN GORDON,BRINER KARIN,COHEN MICHAEL PHILIP,GALKA CHRISTOPHER STANLEY,HELLMAN SARAH LYNNE,MARTINEZ-GRAU MARIA ANGELES,REINHARD MATTHEW ROBERT,RODRIGUEZ MICHAEL JOHN,ROTHHAAR ROGER RYAN,TIDWELL,ALLEN John Gordon,BRINER Karin,COHEN Michael Philip,GALKA Christopher Stanley,HELLMAN Sarah Lynne,MART
申请号：
SI200531852
公开号：
SI1720836T1
申请日:
2005.02.18
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT 2C receptor agonists for the treatment of 5-HT 2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: where: R 6 is -S-L-R 15 and other substituents are as defined in the specification.
